204 related articles for article (PubMed ID: 19120700)
1. The potential role of MLC phosphatase and MAPK signalling in the pathogenesis of vascular dysfunction in heart failure.
Ogut O; Brozovich FV
J Cell Mol Med; 2008 Dec; 12(6A):2158-64. PubMed ID: 19120700
[TBL] [Abstract][Full Text] [Related]
2. Captopril prevents myosin light chain phosphatase isoform switching to preserve normal cGMP-mediated vasodilatation.
Chen FC; Ogut O; Rhee AY; Hoit BD; Brozovich FV
J Mol Cell Cardiol; 2006 Sep; 41(3):488-95. PubMed ID: 16815432
[TBL] [Abstract][Full Text] [Related]
3. Losartan decreases p42/44 MAPK signaling and preserves LZ+ MYPT1 expression.
Ararat E; Brozovich FV
PLoS One; 2009; 4(4):e5144. PubMed ID: 19357768
[TBL] [Abstract][Full Text] [Related]
4. Vascular reactivity in heart failure: role of myosin light chain phosphatase.
Karim SM; Rhee AY; Given AM; Faulx MD; Hoit BD; Brozovich FV
Circ Res; 2004 Sep; 95(6):612-8. PubMed ID: 15321927
[TBL] [Abstract][Full Text] [Related]
5. Unzipping the role of myosin light chain phosphatase in smooth muscle cell relaxation.
Huang QQ; Fisher SA; Brozovich FV
J Biol Chem; 2004 Jan; 279(1):597-603. PubMed ID: 14530290
[TBL] [Abstract][Full Text] [Related]
6. MYPT1 protein isoforms are differentially phosphorylated by protein kinase G.
Yuen S; Ogut O; Brozovich FV
J Biol Chem; 2011 Oct; 286(43):37274-9. PubMed ID: 21890627
[TBL] [Abstract][Full Text] [Related]
7. Differential phosphorylation of LZ+/LZ- MYPT1 isoforms regulates MLC phosphatase activity.
Yuen SL; Ogut O; Brozovich FV
Arch Biochem Biophys; 2014 Nov; 562():37-42. PubMed ID: 25168281
[TBL] [Abstract][Full Text] [Related]
8. Gene expression profiles of vascular smooth muscle show differential expression of mitogen-activated protein kinase pathways during captopril therapy of heart failure.
Chen FC; Brozovich FV
J Vasc Res; 2008; 45(5):445-54. PubMed ID: 18418003
[TBL] [Abstract][Full Text] [Related]
9. Redox signaling and splicing dependent change in myosin phosphatase underlie early versus late changes in NO vasodilator reserve in a mouse LPS model of sepsis.
Reho JJ; Zheng X; Asico LD; Fisher SA
Am J Physiol Heart Circ Physiol; 2015 May; 308(9):H1039-50. PubMed ID: 25724497
[TBL] [Abstract][Full Text] [Related]
10. The involvement of phosphorylation of myosin phosphatase targeting subunit 1 (MYPT1) and MYPT1 isoform expression in NO/cGMP mediated differential vasoregulation of cerebral arteries compared to systemic arteries.
Lubomirov LT; Papadopoulos S; Filipova D; Baransi S; Todorović D; Lake P; Metzler D; Hilsdorf S; Schubert R; Schroeter MM; Pfitzer G
Acta Physiol (Oxf); 2018 Sep; 224(1):e13079. PubMed ID: 29694711
[TBL] [Abstract][Full Text] [Related]
11. Myosin phosphatase isoform switching in vascular smooth muscle development.
Payne MC; Zhang HY; Prosdocimo T; Joyce KM; Koga Y; Ikebe M; Fisher SA
J Mol Cell Cardiol; 2006 Feb; 40(2):274-82. PubMed ID: 16356512
[TBL] [Abstract][Full Text] [Related]
12. Degradation of leucine zipper-positive isoform of MYPT1 may contribute to development of nitrate tolerance.
Dou D; Ma H; Zheng X; Ying L; Guo Y; Yu X; Gao Y
Cardiovasc Res; 2010 Apr; 86(1):151-9. PubMed ID: 19939965
[TBL] [Abstract][Full Text] [Related]
13. A splice variant of the myosin phosphatase regulatory subunit tunes arterial reactivity and suppresses response to salt loading.
Reho JJ; Kenchegowda D; Asico LD; Fisher SA
Am J Physiol Heart Circ Physiol; 2016 Jun; 310(11):H1715-24. PubMed ID: 27084390
[TBL] [Abstract][Full Text] [Related]
14. Tissue-specific expression of myosin phosphatase subunits and isoforms in smooth muscle of mice and humans.
Oslin K; Reho JJ; Lu Y; Khanal S; Kenchegowda D; Prior SJ; Fisher SA
Am J Physiol Regul Integr Comp Physiol; 2022 Apr; 322(4):R281-R291. PubMed ID: 35107022
[TBL] [Abstract][Full Text] [Related]
15. Dynamic changes in expression of myosin phosphatase in a model of portal hypertension.
Payne MC; Zhang HY; Shirasawa Y; Koga Y; Ikebe M; Benoit JN; Fisher SA
Am J Physiol Heart Circ Physiol; 2004 May; 286(5):H1801-10. PubMed ID: 14704233
[TBL] [Abstract][Full Text] [Related]
16. Editing of the myosin phosphatase regulatory subunit suppresses angiotensin II induced hypertension via sensitization to nitric oxide mediated vasodilation.
Htet M; Ursitti JA; Chen L; Fisher SA
Pflugers Arch; 2021 Apr; 473(4):611-622. PubMed ID: 33145641
[TBL] [Abstract][Full Text] [Related]
17. Role of myosin phosphatase isoforms in cGMP-mediated smooth muscle relaxation.
Khatri JJ; Joyce KM; Brozovich FV; Fisher SA
J Biol Chem; 2001 Oct; 276(40):37250-7. PubMed ID: 11486008
[TBL] [Abstract][Full Text] [Related]
18. MYPT1 mutants demonstrate the importance of aa 888-928 for the interaction with PKGIalpha.
Given AM; Ogut O; Brozovich FV
Am J Physiol Cell Physiol; 2007 Jan; 292(1):C432-9. PubMed ID: 16870832
[TBL] [Abstract][Full Text] [Related]
19. Increased degradation of MYPT1 contributes to the development of tolerance to nitric oxide in porcine pulmonary artery.
Ma H; He Q; Dou D; Zheng X; Ying L; Wu Y; Raj JU; Gao Y
Am J Physiol Lung Cell Mol Physiol; 2010 Jul; 299(1):L117-23. PubMed ID: 20418385
[TBL] [Abstract][Full Text] [Related]
20. MYPT1 isoforms expressed in HEK293T cells are differentially phosphorylated after GTPγS treatment.
Lin S; Brozovich FV
J Smooth Muscle Res; 2016; 52(0):66-77. PubMed ID: 27725371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
